Resources
- Analytical Instruments General
- Chromatography
- Spectroscopy
- Microscopy
- Fluroescence Microscopy (FM)
- Optical microscopes
- Fibre Optic Imaging
- Atomic Force Microscopy (AFM)
- Electron microscopy systems
- Scanning Probe Microscopy Systems
- Ion Microscopy
- Secondary Ion Mass Spectrometry (SIMS)
- Scanning Electron Microscopes (SEM)
- Transmisson Electron Microscopes
- Raman Microscopes
- Nano-optical devices(NSOM),
- Imaging Systems
- Cameras/grabbers
- X-Ray Analysis
- Metering
- Moisture Analysis
- Texture Analysis
- Thermal Analysis
- Particle Analysis
- Polarimetry
- Refractometry
- Lab-on-a-chip systems
- Viscometry and Rheometry
- Voltammetry
- Electrophoresis
- Laboratory equipment and wares
- Air Control/Ventilation equipment
- Mixing and blending
- Baths and Circulators
- Automated Systems
- Shakers
- Workstations, Furniture
- Gas handling
- Safety
- Stirrers
- Heating
- Distillation equipment
- Laboratory glassware
- Liquid handling
- Electrophoresis
- Cooling and refrigeration
- Washing and sterilisation equipment
- Separation equipment
- Purification Equipment
- lighting and illumination
- Vacuum Equipment
- Pumps/valves/tubing
- Milling and grinding
- HTS and combinatorial chemistry equipment
- Water purification
- Evaporation equipment
- Microwave systems
- Weighing and balancing
- Lab Informatics
- Analytical Instruments - Clinical & Lifescience
- Cytometry (Cell Imaging)
- Cytometry (Cell sorting)
- Cytometry(Cell Size analysis and counting)
- 2D and 3D Cell-based assays
- Biosensors
- Calorimeters
- Immunoassays
- High throughput RNAi screening platforms
- High throughput sequencing platforms
- DNA sequence analysers
- Microarray scanners
- Surface plasmon resonance (SPR) Spectrometer
- Circular Dichroism Spectropolarimeter
- Synthesis systems
- Biochemistry Analysers
- Blood Analysers
- Laboratory Equipment & Wares - Clinical & Lifescience
Latest Articles
Cambridge spin-out secures £2.4 million for tumour treatments
| Added: 21 Jun 2022
University of Cambridge spin-out Spirea Limited has secured £2.4 million in funding from British and American investors to increase drug development.
